| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±4.0% | -9.0% | under-priced |
| 05/06/2026 | ±2.7% | -20.3% | under-priced |
| 11/04/2025 | ±3.0% | -8.5% | under-priced |
| 08/06/2025 | ±3.5% | +0.2% | over-priced |
| 05/07/2025 | ±2.4% | +7.1% | under-priced |
| 10/30/2024 | ±1.7% | -11.3% | under-priced |
| 07/31/2024 | ±2.2% | -6.2% | under-priced |
| 05/01/2024 | ±1.7% | -11.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.15 | $6.6B | $274M |
| Q1 FY2026 | $1.82 | $5.7B | $235M |
| Q4 FY2025 | $2.14 | $5.5B | $280M |
| Q3 FY2025 | $2.21 | $5.7B | $291M |
CDW Corporation (CDW) reports in 75 days, with the next report estimated for 11/26/2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 9.2% on average — the market has tended to under-price CDW's earnings risk. Fundamentals into the print: EPS up 4.9% year-over-year, revenue up 10.0%. QuantLogix's live 5-factor engine currently reads CDW as a buy at 77/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →